Abhi Gholap, an accomplished professional with an MBA from Stanford University Graduate School of Business and an M.Tech. from IIT Mumbai, serves as the Founder CEO of OptraSCAN, a cutting-edge AI-enabled Telepathology venture. He is also a Board Member at TiE Silicon Valley, California, and actively contributes as an Investor and Board Member at Sand Hill Angels, California, and Stanford Angels. With a notable track record, he received the "Entrepreneur of the year 2022" award and is recognized for his contributions in "Disruptive innovation for Women's Healthcare" and the President's "Gold Lotus National Award." Abhi's extensive experience includes successful acquisitions of his previous two startups by Roche in 2010 and Beckton Dickinson in 2015. He holds an impressive portfolio of 21 international patents, including 9 in Digital Pathology, and has authored 76 publications in renowned journals, including Nature, Lancet, IEEE, and Applied IHC & Morphology journal, focusing on Medical Devices, AI in Healthcare, and Digital Pathology and Cytology.